A Randomized, Controlled Trial of ZMapp for Ebola Virus Infection - Test2 - elhamkhani - TriplyDB

A Randomized, Controlled Trial of ZMapp for Ebola Virus Infection

A Randomized, Controlled Trial of ZMapp for Ebola Virus Infection

http://www.wikidata.org/entity/Q34542427

about

Insights from clinical research completed during the west Africa Ebola virus disease epidemic.The ongoing evolution of antibody-based treatments for Ebola virus infection.Experimental Therapies for Ebola Virus Disease: What Have We Learned?Public health impact of the 2014-2015 Ebola outbreak in West Africa: seizing opportunities for the future.Clinical Evaluation of Ebola Virus Disease Therapeutics.The natural history of acute Ebola Virus Disease among patients managed in five Ebola treatment units in West Africa: A retrospective cohort study.From hybridomas to a robust microalgal-based production platform: molecular design of a diatom secreting monoclonal antibodies directed against the Marburg virus nucleoprotein.Emerging sexually transmitted viral infections: 1. Review of Ebola virus disease.Discovering Drugs for the Treatment of Ebola Virus.Novel Stable Ebola Virus Minigenome Replicon Reveals Remarkable Stability of the Viral Genome.Dengue Virus Evades AAV-Mediated Neutralizing Antibody Prophylaxis in Rhesus Monkeys.Antibodies from a Human Survivor Define Sites of Vulnerability for Broad Protection against Ebolaviruses.A Sensitive in Vitro High-Throughput Screen To Identify Pan-filoviral Replication Inhibitors Targeting the VP35-NP Interface.[Science in a crisis. Medical countermeasures in Ebola virus disease, 2016: lessons learned and perspectives].Hitting Ebola, to the power of two.Therapeutics Against Filovirus Infection.Rationale for Adjunctive Therapies for Pediatric Sepsis Induced Multiple Organ Failure.Middle East Respiratory Syndrome and Severe Acute Respiratory Syndrome: Current Therapeutic Options and Potential Targets for Novel Therapies.[Integrating clinical research into epidemic response: the field perspective in the Ebola experience].A Systematic Review of Computational Drug Discovery, Development, and Repurposing for Ebola Virus Disease Treatment.Crystallizable Fragment Glycoengineering for Therapeutic Antibodies Development.Rigorous Clinical Trial Design in Public Health Emergencies Is Essential.Protected to death: systematic exclusion of pregnant women from Ebola virus disease trials.Nubia's mother: being pregnant in the time of experimental vaccines and therapeutics for Ebola.Improving readiness for recruitment through simulated trial activation: the Adjuvant Steroids in Adults with Pandemic influenza (ASAP) trial.Antibody therapies for the prevention and treatment of viral infections.Strategies Using Bio-Layer Interferometry Biosensor Technology for Vaccine Research and Development.Treatment-focused Ebola trials, supportive care and future of filovirus care.Intramuscular Adeno-Associated Virus-Mediated Expression of Monoclonal Antibodies Provides 100% Protection Against Ebola Virus Infection in Mice.Ebola Infection in Pregnancy: A Global Perspective and Lessons Learned.Recombinant Antibodies to the Ebola Virus Glycoprotein.The Marburgvirus-Neutralizing Human Monoclonal Antibody MR191 Targets a Conserved Site to Block Virus Receptor Binding.Disaster Preparedness: Biological Threats and Treatment Options.The Unexpected Impact of Vaccines on Secondary Bacterial Infections Following Influenza.Cloning and plant-based production of antibody MC10E7 for a lateral flow immunoassay to detect [4-arginine]microcystin in freshwater.Antiviral efficacy of favipiravir against Ebola virus: A translational study in cynomolgus macaques.Design and evaluation of bi- and trispecific antibodies targeting multiple filovirus glycoproteins.ZMappTM Reinforces the Airway Mucosal Barrier Against Ebola Virus.Plant-made Salmonella bacteriocins salmocins for control of Salmonella pathovars.Safeguarding against Ebola: Vaccines and therapeutics to be stockpiled for future outbreaks.

P2860

Q30234590-EB860ED7-BCA8-40B9-A817-022307C74636 Q30235022-D35ECEB5-9C32-484B-A187-911B79366CFA Q30275032-396CAB7C-DA92-4E1D-B69A-DC1EA5C0608D Q33699174-70AB8547-5B76-43EE-A41C-785F8FCE2FB4 Q38617605-B0980B01-34CC-4B82-8EE0-9329F812FB86 Q38655105-3F1FAA05-1240-4719-B83D-F13EC1E79513 Q38696255-810C6517-BF66-4EE1-BDB0-751CB898DEC1 Q38841962-A9EBA912-18C5-4A5A-BDE4-1978A665CAEC Q40039706-96958E9B-BD03-4EEA-83EF-EDDAC8BF43E1 Q40040437-DEBB451D-89E8-44A2-92ED-C10F12F26F2A Q40045875-45C92AF2-60BF-4341-A497-085E01F6944D Q40056187-3F9D410B-E05A-4755-8978-E28BD2B5CF03 Q40070709-F713B290-288E-4417-914E-D5B39259B050 Q40079929-FB0BE319-5C5E-4FF9-B844-5EC271DD5889 Q40080010-0C211A4C-10C8-46FE-B7CE-52123E226C74 Q40144389-FC1AFF71-9F60-447B-9950-366B4E840AEA Q41994903-2D318126-7766-4D91-ACE8-F575363047FF Q43280688-7BAB4470-C27B-4A79-96C3-C012A85214F5 Q44105836-AD7FECD8-BEB9-4CC1-A37E-CC5B0FA85A06 Q44105963-7FB26F72-993D-4C46-997A-9350DF57DAB5 Q44852748-4CC79B0B-9255-46CF-B1E4-17B879FDE633 Q46166921-7170909A-A63F-4528-9ADD-5E092E186E65 Q47116619-B0C30871-EA0A-49C8-9A1D-67158219C12A Q47135161-2DE27E21-D257-43AA-9BFC-A715B830437B Q47140657-A617602D-CD4B-4A33-9410-863D9DAB529B Q47143843-0CD05979-7CF8-4DEF-A479-56403024C870 Q47171892-230B1275-A2F4-4DC8-9E96-7B1979D2DB89 Q47360326-5ADEC598-9799-46B7-B190-C7A92FB30182 Q47549288-F69A8E8F-D221-4B0B-ADFB-B58FBE786B3F Q47551297-EEF65524-2BCE-48B6-93CE-BA539A191344 Q47552699-7F3C01C4-6740-4AE7-96C6-4EC8000E85F3 Q47555346-FE6F4E2D-6CA9-4C10-971E-5D2AB01E450F Q47558565-DADCB0AB-AB7F-47D4-96EA-6FAEF6E29715 Q47576940-B90F85C2-CA5F-4761-BEF1-5375951A1B93 Q49747358-B4BDE166-9662-49F2-8B53-9CC307B95960 Q51782887-ACF39C3E-DDF1-4C4F-9AA8-2AAEB0A58821 Q51784478-087A95EF-77FB-408F-AF1A-37B08D67A6E2 Q54107825-9FCF37DC-727F-49DA-BC35-D8995E4FA2F4 Q54988047-FB908BA3-ED20-465B-BF36-BBA123692008 Q55026054-0AF9EEA7-9F8D-49F1-A9A4-8B3323F5B794

P2860

A Randomized, Controlled Trial of ZMapp for Ebola Virus Infection

http://www.wikidata.org/entity/Q34542427

description

2016 nî lūn-bûn

@nan

2016 թուականի Հոկտեմբերին հրատարակուած գիտական յօդուած

@hyw

2016 թվականի հոտեմբերին հրատարակված գիտական հոդված

@hy

2016年の論文

@ja

2016年論文

@yue

2016年論文

@zh-hant

2016年論文

@zh-hk

2016年論文

@zh-mo

2016年論文

@zh-tw

2016年论文

@wuu

name

A Randomized, Controlled Trial of ZMapp for Ebola Virus Infection

@ast

A Randomized, Controlled Trial of ZMapp for Ebola Virus Infection

@en

A Randomized, Controlled Trial of ZMapp for Ebola Virus Infection

@nl

type

label

A Randomized, Controlled Trial of ZMapp for Ebola Virus Infection

@ast

A Randomized, Controlled Trial of ZMapp for Ebola Virus Infection

@en

A Randomized, Controlled Trial of ZMapp for Ebola Virus Infection

@nl

prefLabel

A Randomized, Controlled Trial of ZMapp for Ebola Virus Infection

@ast

A Randomized, Controlled Trial of ZMapp for Ebola Virus Infection

@en

A Randomized, Controlled Trial of ZMapp for Ebola Virus Infection

@nl

P1433

Q34542427-AD4D409A-5192-4EB7-9E6E-943DE433F84C

P1476

Q34542427-1ABB2A74-67BF-4B77-A057-5D1659B8E50F

P2093

Q34542427-1127DCD3-BD38-4278-A6AF-D2807AC6D19B

Q34542427-2645E497-EEA2-4FBC-9915-3AE9DAF5DDDF

Q34542427-26D64051-39A9-4C83-8362-A5107A09EE7A

Q34542427-417B585C-6891-4AED-B2F5-B60BC323D556

Q34542427-69471E5A-8EFF-4431-92E4-59CC7A2C17CE

Q34542427-7CD850AD-8F3E-428F-AC1A-AA81E0899421

Q34542427-8CAA3233-6CF9-4C6D-9B0A-B534AE690B4C

Q34542427-8FE86C7F-8D26-4FBA-8275-ADB9EABC7F88

Q34542427-AD8D35C5-E5E2-4CA1-A6CE-AF1E6B8ABA50

Q34542427-C0CB4E86-C45F-498D-89FA-574065D6343B

P2860

Q34542427-03E12BC0-A755-400B-B3C0-02500A9A3F03

Q34542427-0EA3ED89-752B-4859-AC20-6AC56AE861F4

Q34542427-270CFE07-529D-4CD4-9824-4A85150622A4

Q34542427-2887F7B9-2D7E-4D00-8C47-E8D0F301C883

Q34542427-29033FDC-3268-40C1-AA31-E8532E7756F8

Q34542427-29C05CBC-6A14-4001-B579-3D85B19C4147

Q34542427-2B7594AD-19FD-4385-AE75-7010BCE77260

Q34542427-30EEB25D-12FE-423F-9FA8-A0B133009D55

Q34542427-62069B43-B385-4A93-B5E1-126B6D48B600

Q34542427-6A7AC208-5D79-4940-BDAC-FCA185477540

P304

Q34542427-556FA183-65C2-465D-ABA5-691B2E7A97F3

P31

Q34542427-85A0CC55-B341-4554-8500-1F99D33EC40D

P356

Q34542427-A95AA877-5610-43EA-8CFE-62E3C71B874E

P407

Q34542427-E1CFBA81-BED6-4409-95EA-47FA0F850EA8

P433

Q34542427-58DE9906-9D2F-4478-B5A0-FF013CE1181B

P478

Q34542427-52648837-A76D-4F3A-9E32-9AE24E6D910C

P50

Q34542427-49C5FB6B-5D0D-4BF2-BC6A-8C4EA5CC128C

Q34542427-7F33DE25-7B62-4A5B-929A-7742FE74BC96

Q34542427-9C483743-2F71-40F7-9389-EC588CD6202E

Q34542427-F48C7760-9FF5-4F70-B02A-ABEBF14BCBFD

P577

Q34542427-2ABB6B6D-97D2-4763-A603-11AB0C26814C

P698

Q34542427-71FA0C5C-826B-4E2C-B1B1-58CD08DD9F4D

P921

Q34542427-5E3FFD29-4D8A-4322-A1C9-29C5460482D9

P932

Q34542427-6C9D3072-54B2-41DF-8966-9AA83F7BA5BF

P356

P1433

The New England Journal of Medicine

P1476

A Randomized, Controlled Trial of ZMapp for Ebola Virus Infection

@en

P2093

Denis Malvy

http://www.w3.org/2001/XMLSchema#string

Foday Sahr

http://www.w3.org/2001/XMLSchema#string

Jacquie Neuhaus Nordwall

http://www.w3.org/2001/XMLSchema#string

James Neaton

http://www.w3.org/2001/XMLSchema#string

John Tierney

http://www.w3.org/2001/XMLSchema#string

Joseph S Koopmeiners

http://www.w3.org/2001/XMLSchema#string

Michael A Proschan

http://www.w3.org/2001/XMLSchema#string

Moses B F Massaquoi

http://www.w3.org/2001/XMLSchema#string

Multi-National PREVAIL II Study Team

http://www.w3.org/2001/XMLSchema#string

PREVAIL II Writing Group

http://www.w3.org/2001/XMLSchema#string

P2860

Ebola haemorrhagic fever in Zaire, 1976

Prognostic Indicators for Ebola Patient Survival

Evaluating interventions for Ebola: The need for randomized trials

Design of a Randomized Controlled Trial for Ebola Virus Disease Medical Countermeasures: PREVAIL II, the Ebola MCM Study

Experimental Treatment with Favipiravir for Ebola Virus Disease (the JIKI Trial): A Historically Controlled, Single-Arm Proof-of-Concept Trial in Guinea

Clinical presentation, biochemical, and haematological parameters and their association with outcome in patients with Ebola virus disease: an observational cohort study.

Protection against filovirus diseases by a novel broad-spectrum nucleoside analogue BCX4430.

Ebola virus (EBOV) infection: Therapeutic strategies.

Reliable assessment of the effects of treatment on mortality and major morbidity, I: clinical trials.

Reversion of advanced Ebola virus disease in nonhuman primates with ZMapp

P304

1448-1456

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1056/NEJMOA1604330

http://www.w3.org/2001/XMLSchema#string

P407

P433

15

http://www.w3.org/2001/XMLSchema#string

P478

375

http://www.w3.org/2001/XMLSchema#string

P50

H. Clifford Lane

P577

2016-10-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

27732819

http://www.w3.org/2001/XMLSchema#string

P921

P932

5086427

http://www.w3.org/2001/XMLSchema#string